EX-99.A 2 tm2424212d1_ex99a.htm EXHIBIT 99.A

 

EXHIBIT A

 

JOINT FILING AGREEMENT

 

The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Janux Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.

 

Dated: September 16, 2024

 

AVALON VENTURES XI, L.P.   AVALON VENTURES XI GP LLC
     
By: /s/ Tighe Reardon   By: /s/ Tighe Reardon
  Name: Tighe Reardon     Name: Tighe Reardon
  Title: Authorized Signer     Title: Authorized Signer
     
     
AVALON  BIOVENTURES SPV I, L.P.   ABV SPV I GP LLC
     
By: /s/ Tighe Reardon   By: /s/ Tighe Reardon
  Name: Tighe Reardon     Name: Tighe Reardon
  Title: Authorized Signer     Title: Authorized Signer
     
     
AVALON BIOVENTURES I, LP   AVALON BIOVENTURES GP, LLC
     
By: /s/ Tighe Reardon   By: /s/ Tighe Reardon
  Name: Tighe Reardon     Name: Tighe Reardon
  Title: Authorized Signer     Title: Authorized Signer
     
     
/s/ Kevin Kinsella   /s/ Tighe Reardon
Kevin Kinsella   Tighe Reardon
     
     
/s/ Richard Levandov   /s/ Sergio Duron
Richard Levandov   Sergio G. Duron, Ph.D.
     
     
/s/ Braden Bohrmann   /s/ Sanford Madigan
Braden Bohrmann   Sanford Madigan, Ph.D.
     
     
/s/ Jay Lichter    
Jay Lichter, Ph.D.    

 

 

 

SCHEDULE A

 

Transaction  Seller  Date  No. Shares   Price 
Open market sale of Common Stock  Avalon Ventures  9/6/2024   108,365   $42.00 
Open market sale of Common Stock  Avalon Ventures  9/10/2024   11,319   $46.13(1)
Open market sale of Common Stock  Avalon Ventures  9/10/2024   34,326   $46.66(2)
Open market sale of Common Stock  Avalon Ventures  9/12/2024   158,031   $47.00 
Open market sale of Common Stock  ABV SPV  9/6/2024   110,644   $42.00 
Open market sale of Common Stock  ABV SPV  9/10//2024  11,557   $46.13(1)
Open market sale of Common Stock  ABV SPV  9/10/2024   35,047   $46.66(2)
Open market sale of Common Stock  ABV SPV  9/12/2024   161,356   $47.00 
Open market sale of Common Stock  ABV I  9/6/2024   20,991   $42.00 
Open market sale of Common Stock  ABV I  9/10/2024   2,193   $46.13(1)
Open market sale of Common Stock  ABV I  9/10/2024   6,649   $46.66(2)
Open market sale of Common Stock  ABV I  9/12/2024   30,613   $47.00 
Open market sale of Common Stock  Lichter  9/9/2024   2,182   $42.33(3)
Open market sale of Common Stock  Reardon  9/9/2024   15,031   $42.14 
Open market sale of Common Stock  Reardon  9/10/24   5,359   $45.87 
Open market sale of Common Stock  Reardon  9/12/24   24,042   $47.55 
Open market sale of Common Stock  Duron  9/9/2024   3,054   $42.47 
Open market sale of Common Stock  Duron  9/10/24   1,096   $46.01 
Open market sale of Common Stock  Duron  9/12/24   5,253   $47.80 
Open market sale of Common Stock  Madigan  9/9/24   6,142   $48.00 
Open market sale of Common Stock  Madigan  9/10/24   1,278   $45.91 
Open market sale of Common Stock  Madigan  9/12/24   6,142   $48.00 

 

(1)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.50 to $46.47 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

 

(2)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.50 to $47.02 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

 

(3)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.33 to $42.39 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.